tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniil Gataulin, 26 are a BUY (81.25%), 6 are a HOLD (18.75%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 9.29% that have a potential upside of 27.04% achieved within 125 days.
Daniil Gataulin’s has documented 60 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 29-Oct-2024.
Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 8/3/2023. The price target of $22 was fulfilled within 141 days with a profit of $9.47 (75.58%) receiving and performance score of 5.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$10
$3.14 (45.77%)
$12
17 days ago
(05-Nov-2024)
1/6 (16.67%)
$2.39 (31.41%)
35
Buy
$30
$23.14 (337.32%)
$30
3 months 9 days ago
(13-Aug-2024)
0/3 (0%)
$23.24 (343.79%)
Buy
$40
$33.14 (483.09%)
$4
4 months 4 days ago
(18-Jul-2024)
1/4 (25%)
$30.52 (321.94%)
543
Buy
$22
$15.14 (220.70%)
$40
6 months 24 days ago
(29-Apr-2024)
2/5 (40%)
$12.47 (130.85%)
52
Buy
$6
$4.05 (207.69%)
$4
1 years 2 months 17 days ago
(05-Sep-2023)
4/7 (57.14%)
$4.22 (237.08%)
196
Which stock is Daniil Gataulin is most bullish on?
Which stock is Daniil Gataulin is most reserved on?
What Year was the first public recommendation made by Daniil Gataulin?
